{"id":{"repo_id":"gatech","oai_identifier":"oai:repository.gatech.edu:1853/52154"},"canonical_url":"https://search.ndltd.org/etd/gatech/oai:repository.gatech.edu:1853/52154","repository":{"repo_id":"gatech","name":"Georgia Tech","base_url":"https://repository.gatech.edu/server/oai/request"},"display":{"title":"Microfluidic system for thrombosis under multiple shear rates and platelet therapies","abstract":"Thrombosis is the pathological formation of platelet aggregates that cause stroke and heart attack\\textemdash the leading causes of death in developed nations. Determining effective dosages for platelet therapies (e.g. aspirin, Integrilin, and Plavix) to prevent thrombosis is a persistent medical challenge (studies estimate up to 45% of patients exhibit insufficient responses to these drugs) and recent studies have implicated pathological flow conditions of high shear rates and stenosis morphology as primary factors. However, there are currently no diagnostic instruments able to recapitulate a range of such pathological flow conditions for evaluating thrombosis with and without these drugs. In this work, a microfluidic device and associated optical system were designed and fabricated for simultaneous measurement of platelet aggregation at multiple initial wall shear rates within multiple stenotic channels in label-free whole blood and used to characterize thrombosis at varying dosages of two platelet therapies: acetyl-salicylic acid (aspirin) and eptifibatide (Integrilin). Results from our studies show the effects of pathologically high shear rates on enhancing platelet thrombosis and demonstrate the widely varied, shear-dependent efficacy of each therapy. This study lays the foundation for the future development of a medical diagnostic for optimizing the type and dosage of patient platelet therapy and to better understand their mechanisms of action.","abstract_html":"Thrombosis is the pathological formation of platelet aggregates that cause stroke and heart attack\\textemdash the leading causes of death in developed nations. Determining effective dosages for platelet therapies (e.g. aspirin, Integrilin, and Plavix) to prevent thrombosis is a persistent medical challenge (studies estimate up to 45% of patients exhibit insufficient responses to these drugs) and recent studies have implicated pathological flow conditions of high shear rates and stenosis morphology as primary factors. However, there are currently no diagnostic instruments able to recapitulate a range of such pathological flow conditions for evaluating thrombosis with and without these drugs. In this work, a microfluidic device and associated optical system were designed and fabricated for simultaneous measurement of platelet aggregation at multiple initial wall shear rates within multiple stenotic channels in label-free whole blood and used to characterize thrombosis at varying dosages of two platelet therapies: acetyl-salicylic acid (aspirin) and eptifibatide (Integrilin). Results from our studies show the effects of pathologically high shear rates on enhancing platelet thrombosis and demonstrate the widely varied, shear-dependent efficacy of each therapy. This study lays the foundation for the future development of a medical diagnostic for optimizing the type and dosage of patient platelet therapy and to better understand their mechanisms of action.","abstract_has_math":false,"creators":["Li, Melissa"],"institution":"Georgia Institute of Technology","degree_name":null,"degree_level":"Doctoral","degree_discipline":null,"degree_department":"Biomedical Engineering (Joint GT/Emory Department)","school":null,"contributors":[],"advisors":["Forest, Craig R."],"committee_chairs":[],"committee_members":["Ackerman, Jeremy D.","Gleason, Rudolph L.","Ku, David N.","Platt, Manu O."],"year":2013,"date_issued":"2013-05-13","date_published":"2013-05-13","updated_at":"2026-11-19T03:55:01Z","subjects":["Microfluidics","Thrombosis","Shear","Platelets","Platelet therapy","Aspirin","Eptifibatide","Dose"],"languages":["en_US"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"http://hdl.handle.net/1853/52154","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"http://hdl.handle.net/1853/52154","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://repository.gatech.edu/server/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Arepository.gatech.edu%3A1853%2F52154","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Forest, Craig R."]},{"key":"dc:contributor.committeemember","label":"Committee Member","values":["Ackerman, Jeremy D.","Gleason, Rudolph L.","Ku, David N.","Platt, Manu O."]},{"key":"dc:contributor.department","label":"Department","values":["Biomedical Engineering (Joint GT/Emory Department)"]},{"key":"dc:contributor.other","label":"Dc Contributor Other","values":["Wallace H. Coulter Department of Biomedical Engineering","College of Engineering"]},{"key":"dc:creator","label":"Author","values":["Li, Melissa"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2014-08-27T13:31:32Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2014-08-27T13:31:32Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2013-08"]},{"key":"dc:date.issued","label":"Date","values":["2013-05-13"]},{"key":"dc:date.submitted","label":"Dc Date Submitted","values":["August 2013"]},{"key":"dc:date.updated","label":"Dc Date Updated","values":["2014-08-27T13:31:32Z"]},{"key":"dc:publisher","label":"Institution","values":["Georgia Institute of Technology"]},{"key":"dc:relation.advisorentity","label":"Dc Relation Advisorentity","values":["deef8ba6-503e-4cb0-b316-c3949aca6851"]},{"key":"dc:relation.ispartofseries","label":"Dc Relation Ispartofseries","values":["Doctor of Philosophy with a Major in Biomedical Engineering"]},{"key":"dc:relation.orgunit","label":"Dc Relation Orgunit","values":["da59be3c-3d0a-41da-91b9-ebe2ecc83b66","7c022d60-21d5-497c-b552-95e489a06569"]},{"key":"dc:relation.seriesentity","label":"Dc Relation Seriesentity","values":["d85f9f1b-b2b5-4bca-81af-4515c5281e54"]},{"key":"dc:type","label":"Dc Type","values":["Text","Dissertation"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Doctoral"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Microfluidics","Thrombosis","Shear","Platelets","Platelet therapy","Aspirin","Eptifibatide","Dose"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en_US"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://hdl.handle.net/1853/52154"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Thrombosis is the pathological formation of platelet aggregates that cause stroke and heart attack\\textemdash the leading causes of death in developed nations. Determining effective dosages for platelet therapies (e.g. aspirin, Integrilin, and Plavix) to prevent thrombosis is a persistent medical challenge (studies estimate up to 45% of patients exhibit insufficient responses to these drugs) and recent studies have implicated pathological flow conditions of high shear rates and stenosis morphology as primary factors. However, there are currently no diagnostic instruments able to recapitulate a range of such pathological flow conditions for evaluating thrombosis with and without these drugs. In this work, a microfluidic device and associated optical system were designed and fabricated for simultaneous measurement of platelet aggregation at multiple initial wall shear rates within multiple stenotic channels in label-free whole blood and used to characterize thrombosis at varying dosages of two platelet therapies: acetyl-salicylic acid (aspirin) and eptifibatide (Integrilin). Results from our studies show the effects of pathologically high shear rates on enhancing platelet thrombosis and demonstrate the widely varied, shear-dependent efficacy of each therapy. This study lays the foundation for the future development of a medical diagnostic for optimizing the type and dosage of patient platelet therapy and to better understand their mechanisms of action."]},{"key":"dc:description.degree","label":"Dc Description Degree","values":["Ph.D."]},{"key":"dc:format.mimetype","label":"Dc Format Mimetype","values":["application/pdf"]},{"key":"dc:title","label":"Title","values":["Microfluidic system for thrombosis under multiple shear rates and platelet therapies"]},{"key":"dspace:entity.type","label":"Dspace Entity Type","values":["Publication"]}]}],"canonical_facts":{"dc:contributor.advisor":["Forest, Craig R."],"dc:contributor.committeemember":["Ackerman, Jeremy D.","Gleason, Rudolph L.","Ku, David N.","Platt, Manu O."],"dc:contributor.department":["Biomedical Engineering (Joint GT/Emory Department)"],"dc:contributor.other":["Wallace H. Coulter Department of Biomedical Engineering","College of Engineering"],"dc:creator":["Li, Melissa"],"dc:date.accessioned":["2014-08-27T13:31:32Z"],"dc:date.available":["2014-08-27T13:31:32Z"],"dc:date.created":["2013-08"],"dc:date.issued":["2013-05-13"],"dc:date.submitted":["August 2013"],"dc:date.updated":["2014-08-27T13:31:32Z"],"dc:description.abstract":["Thrombosis is the pathological formation of platelet aggregates that cause stroke and heart attack\\textemdash the leading causes of death in developed nations. Determining effective dosages for platelet therapies (e.g. aspirin, Integrilin, and Plavix) to prevent thrombosis is a persistent medical challenge (studies estimate up to 45% of patients exhibit insufficient responses to these drugs) and recent studies have implicated pathological flow conditions of high shear rates and stenosis morphology as primary factors. However, there are currently no diagnostic instruments able to recapitulate a range of such pathological flow conditions for evaluating thrombosis with and without these drugs. In this work, a microfluidic device and associated optical system were designed and fabricated for simultaneous measurement of platelet aggregation at multiple initial wall shear rates within multiple stenotic channels in label-free whole blood and used to characterize thrombosis at varying dosages of two platelet therapies: acetyl-salicylic acid (aspirin) and eptifibatide (Integrilin). Results from our studies show the effects of pathologically high shear rates on enhancing platelet thrombosis and demonstrate the widely varied, shear-dependent efficacy of each therapy. This study lays the foundation for the future development of a medical diagnostic for optimizing the type and dosage of patient platelet therapy and to better understand their mechanisms of action."],"dc:description.degree":["Ph.D."],"dc:format.mimetype":["application/pdf"],"dc:identifier.uri":["http://hdl.handle.net/1853/52154"],"dc:language.iso":["en_US"],"dc:publisher":["Georgia Institute of Technology"],"dc:relation.advisorentity":["deef8ba6-503e-4cb0-b316-c3949aca6851"],"dc:relation.ispartofseries":["Doctor of Philosophy with a Major in Biomedical Engineering"],"dc:relation.orgunit":["da59be3c-3d0a-41da-91b9-ebe2ecc83b66","7c022d60-21d5-497c-b552-95e489a06569"],"dc:relation.seriesentity":["d85f9f1b-b2b5-4bca-81af-4515c5281e54"],"dc:subject":["Microfluidics","Thrombosis","Shear","Platelets","Platelet therapy","Aspirin","Eptifibatide","Dose"],"dc:title":["Microfluidic system for thrombosis under multiple shear rates and platelet therapies"],"dc:type":["Text","Dissertation"],"dspace:entity.type":["Publication"],"thesis:degree_level":["Doctoral"]},"updated_at":"2026-11-19T03:55:01Z"}